GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Today
—
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Advanced Enzyme Technologies Ltd
Advanced Enzyme Technologies Bought Back 46,158 Shares on Oct 09, 2026
BUYBACK ▲ Positive Development LOW RISK
📅 Filed on BSE: 09 Oct 2026, 05:25 PM IST  ·  BSE ID: 499c4203-a5ca-40ae-a1a8-ee6d2017f355
View Original BSE Filing (PDF)
💡
In Simple Terms
The company repurchased some of its own shares from the stock market on October 9, 2026.
🤖 AI Summary
  • Advanced Enzyme Technologies bought back 46,158 equity shares on October 9, 2026.
  • The average acquisition price per share for this transaction was ₹269.0242.
  • The buyback is conducted via stock exchanges under SEBI (Buy-Back of Securities) Regulations, 2018.
  • Cumulative shares bought back by the company reached 18,41,482 as of October 9, 2026.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity Shares bought back on October 09, 2026
46,158
Average Price of acquisition on October 09, 2026
269.0242 ₹
Cumulative Equity Shares bought as on October 09, 2026
18,41,482
🏢 How This Affects the Company
💰
Financial Impact
The buyback reduces the number of outstanding shares, potentially increasing earnings per share for remaining shareholders.
⚠️
Risk Impact
The buyback program indicates management's confidence in the company's valuation, but ongoing execution carries financial commitment.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders regarding this daily buyback report.
👤
Who Is Affected
All shareholders are affected as the buyback reduces the total number of outstanding shares.
🔍
Management Signal
Management is actively reducing the equity base, suggesting they believe the shares are undervalued.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Next daily buyback report to confirm continued activity.
Upcoming quarterly results for performance updates.
Company announcements on buyback completion status.
LOW RISK Routine disclosure of share buyback activity under regulatory requirements.
💡 Investor Takeaway
Advanced Enzyme Technologies bought 46,158 shares on Oct 9, 2026, at an average price of ₹269.0242. Total buyback stands at 18,41,482 shares.
⚖️ Strengths & Concerns

✅ Positives

  • Company actively executing share buyback program, demonstrating confidence in valuation.
  • Cumulative buyback of 18,41,482 shares shows sustained commitment to returning capital.
📅 Company Track Record
Previous filings show Advanced Enzyme Technologies bought 26,000 shares on Oct 7, 2026, at ₹272.3684 and 58,774 shares on Sep 1, 2026, at ₹296.0490.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
How many shares did Advanced Enzyme Technologies buy back on October 09, 2026?
Advanced Enzyme Technologies bought back 46,158 equity shares on October 09, 2026.
What was the average acquisition price for shares bought on October 09, 2026?
The average price of acquisition for the shares bought on October 09, 2026, was ₹269.0242.
What is the total number of shares bought back by Advanced Enzyme Technologies to date?
As of October 09, 2026, a total of 18,41,482 equity shares have been bought back.
Under which regulations is Advanced Enzyme Technologies conducting its share buyback?
The buyback is being conducted pursuant to the SEBI (Buy-Back of Securities) Regulations, 2018.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.